IRCT20180422039379N1
Completed
Phase 2
Comparison between the effect of oral and intravenous vitamin D3 on statin-induced myopathy level :Randomized Controlled Trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Statins myopathy.
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. There are symptoms of myalgia with statins
- •2\. Age of patients aged 18 to 65 years.
- •3\. Lower levels of vitamin D (25OH Vitamin D3\) from normal range (\<32ng / ml).
Exclusion Criteria
- •1\. Patient does not provide consent.
- •2\. Failure to complete the study
- •3\. Age under 18 and over 65 years.
- •4\. Alcohol or substance abuse.
- •5\. Collagen disease, vascular, coagulopathy, genetic, cerebrovascular disease.
- •6\. Creatine kinase level above 300U / L, indicating fibromyalgia.
- •7\. The patient is not able to use Pearl vitamin D3 or a tendency to inject a drug.
- •8\. The history and evidence of examination indicate trauma in the organs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparison of the effect of oral and intravenous iron supplementation on quality of life and function of patients with heart failureIRCT20180205038626N15Rasht University of Medical Sciences180
Completed
Not Applicable
Influence of intravenous versus oral administration, arterial versus venous sampling and gender on pharmacokinetic-pharmacodynamic modelling of morphine and morphine-6-glucuronide-induced pain relief in healthy volunteersPost-operative painNot ApplicablePainISRCTN80473151eiden University Medical Centre (LUMC) (Netherlands)60
Recruiting
Phase 3
Comparison of the efficacy of oral, intravenous and topical Tranexamic acid in reducing bleeding after total knee arthroplastyIRCT20180411039272N1Arak University of Medical Sciences135
Active, not recruiting
Phase 1
The efficacy of oral administration of sodium chloride in the prophylaxis of nephropathy induced by iodinated contrastsPatients at high risk of developing an iodinated contrast-induced nephropathy.Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2013-001229-15-ESFundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal266
Not yet recruiting
Phase 2
Oral and injectable antiquaguane in the prevention of thromboembolic eventsCondition 1: Thrombosis. Condition 2: Pulmonary embolism.Acute embolism and thrombosis of deep veins of lower extremityPulmonary embolismI82.4IRCT20231026059867N1Esfahan University of Medical Sciences100